FDA Orange Book · active-ingredient family
Hydrochlorothiazide; losartan potassium
Hydrochlorothiazide; losartan potassium is approved as 1 brand and 18 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:HYZAAR · NDA 020387
1
Brand (NDA)
18
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| HYZAARRLD×3 | ORGANON | NDA 020387 | AB | Apr 28, 1995 |
Generic (ANDA) products (18)
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Hydrochlorothiazide; losartan potassium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

